Showing results (111-120 of 212) with videos related to

Sort By:
Pageof 22
Oncotarget|September 20, 2017
<i>BACH2</i> promotes indolent clinical presentation in Waldenström macroglobulinemiaCharles Herbaux, Elisabeth Bertrand, Guillemette Marot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
<i>TP53</i> Mutation and Its Prognostic Significance in Waldenstrom's MacroglobulinemiaStéphanie Poulain, Christophe Roumier, Elisabeth Bertrand, et al.
Cancers|September 11, 2019
Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive StudyThomas Boyer, Fanny Gonzales, Adeline Barthélémy, et al.
Nature Communications|May 19, 2017
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemiaJean-Baptiste Micol, Alessandro Pastore, Daichi Inoue, et al.
Leukemia Research|August 6, 2010
Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patientsSami Joha, Véronique Dauphin, Frédéric Leprêtre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and olderClaude Gardin, Sylvie Chevret, Cécile Pautas, et al.
Signal Transduction and Targeted Therapy|April 21, 2026
Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemiaFanny Gonzales, Pauline Peyrouze, Djohana Laurent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Genomic Landscape of CXCR4 Mutations in Waldenström MacroglobulinemiaStéphanie Poulain, Christophe Roumier, Aurélie Venet-Caillault, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2021
Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignanciesFlorence Koeppel, Etienne Muller, Alexandre Harlé, et al.
Blood Advances|October 9, 2021
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AMLJuliette Lambert, Jerome Lambert, Xavier Thomas, et al.
Pageof 22